🎙️#BioConversations: Now Streaming on Your Favorite Podcast Platforms! We’re excited to share that BioConversations, our monthly vodcast series featuring #DemystifyingScience, is now available across major streaming platforms. Whether you're commuting, working out, or multitasking, you can now tune in anytime and explore how we simplify the complex science behind lifesaving medicines. 🎧 Listen now: 🔹 [Amazon Music] (https://lnkd.in/egRv5uAR) 🔹 [Apple Podcasts] (https://lnkd.in/eiW9rjfQ) 🔹 [Spotify] (https://lnkd.in/eDD6bM_B) Stay tuned as we bring more conversations that break down complex topics and spark curiosity. #BioConversations — because science should speak your language.
🔬 Calling all Chemistry and Biochemistry lovers! 🎓 Admissions Open for Batch 7 of the Biocon Ramaiah Certificate Program in Quality Control Analytical! Step into an 8-week, full-time journey of hands-on training and skill development. 👉 Learn from experienced faculty at Biocon Academy and Ramaiah College of Arts Science and Commerce 👉 Get hands-on training on QC equipment at Syngene CAPS 👉 100% interview opportunities with the best of companies Link to Apply: https://lnkd.in/gbrrM_5B
Today, on World IBD Day, we at Biocon Biologics stand in solidarity with the millions of people living with Inflammatory Bowel Disease (IBD) such as Crohn's disease and ulcerative colitis. Supporting patients is at the heart of everything we do. That’s why we are committed to advancing access to biosimilars helping healthcare systems deliver sustainable care while empowering patients with more treatment options. Together, we can raise awareness, drive innovation, and make a meaningful difference in the lives of people with #IBD. #WorldIBDDay #IBD #CrohnsDisease #Biosimilars #BioconBiologics #BioconBiologicsEurope #BioconBiologicsCanada #BioconBiologicsUS #HealthcareAccess
India’s Insulin Market is Evolving – and Biocon Biologics is ready. In this conversation, Susheel Umesh, Chief Commercial Officer, shares how Biocon Biologics is stepping up to ensure uninterrupted access to affordable insulin following the phase-out of certain human mixtard pens . With a strong manufacturing footprint, continued investments, and a patient-centric approach, Biocon Biologics is prepared to meet the growing demand and help shape the future of diabetes care — in India and globally. Watch the full discussion: https://lnkd.in/eNArqNxe #BioconBiologics #InsulinAccess #DiabetesCare #Biologics #HealthcareIndia #PharmaLeadership #PatientFirst #InsulinManufacturing
Join our Projects & Engineering team in Bangalore, which manages capital investments for the expansion of DS and DP manufacturing facilities globally that are either greenfield or brownfield. With a team of about 50 split into various verticals including Process Engineering, Automation, and Instrumentation, Electrical, Mechanical, Project Management, Commercial, Civil, and Site execution, we are looking for a Biosimilars Projects Mechanical Lead. If you fit the experience and qualifications in the poster, APPLY TODAY! We can't wait to meet you.
From pioneering discoveries in science to breaking barriers in the world, women have been paving the path for progress for centuries. Our own Founder & Chairperson ranks among them, today. And we continue their legacy in our own ways—driving innovation, advancing healthcare, and shaping a more inclusive future.
On March 19, nearly 70 Biocon Biologics employees in Chennai visited the Spastic Society there, an institution supporting around 250 children with diverse disabilities, including autism. The visit was part of our Belongingness Month activities led by the Chennai Biocon Women’s Network (CHN-BWN). Employees spent a meaningful day distributing educational stationery, sharing meals with the children, and engaging in games, school tours, body percussion, and a pyramid performance by the kids. It was a powerful reminder of the importance of inclusion, empathy, and community engagement—an experience that will stay with all who participated. #LifeatBBL #BioconBiologics #BelongingnessMonth #DEI #SocialImpact #Inclusion #CommunityEngagement
From women to women... On this #InternationalWomensDay, let us introduce you to some of the remarkable women at Biocon Biologics who are behind life-changing biosimilar therapies for breast cancer. Their stories are of dedication, personal connection, a powerful sense of purpose, and we invite you to join us in celebrating them! #IWD2025 #AccelerateAction #FromWomenToWomen
This Thursday, Biocon Biologics’ CEO & Managing Director, Shreehas Tambe, will present at the J.P. Morgan Healthcare Conference in San Francisco, USA. His presentation, “Driving Innovation and Equitable Access to Healthcare,” will highlight the need for patients to have more options for medicines and treatments, how biosimilars present an opportunity to provide savings to patients, Biocon Biologics’ capabilities and more. Watch the video to hear from Shreehas! #BioconBiologics #JPMorganHealthcare #JPMHC2025
Important Update: The U.S. Food and Drug Administration (FDA) has classified Biocon Biologics’ insulin facilities in Johor Bahru, Malaysia as Voluntary Action Indicated (VAI). This relates to the cGMP inspection conducted by the agency between September 15 – 27, 2024. The inspection scope included several biologics manufacturing units comprising one (1) Drug Substance and one (1) Drug Product manufacturing units, one (1) Medical Device Assembly unit, one (1) Analytical Quality Control Laboratory, two (2) Microbiological Control Laboratories and two (2) Warehouses. “Biocon Biologics remains committed to global standards of Quality and Compliance.”– Company Spokesperson Read More: https://bit.ly/PRP20250112
